Kevin J. Curran

Statistics

Publications

Citations

12.3K

H-Index

Active since

1997

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Pearl River Community College

Harvard University

Dana-Farber Cancer Institute

Kevin J. Curran is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and chimeric antigen receptor t-cell therapy.

ORCID

Publications per year

1997–2025

Publications

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

Jae H. Park, Isabelle Rivière, Mithat Gönen et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

Life Sciences, Hematology, Oncology +17

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Marco L. Davila, Isabelle Rivière, Xiuyan Wang et al. · Science Translational Medicine · 2014 · 2.5K citations · Full text

Medicine, Hematology, Oncology +17

CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

Renier J. Brentjens, Marco L. Davila, Isabelle Rivière et al. · Science Translational Medicine · 2013 · 2.1K citations · Full text

Life Sciences, Immunology, Oncology +13

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma

Marcelo C. Pasquini, Zhen‐Huan Hu, Kevin J. Curran et al. · Blood Advances · 2020 · 434 citations · Full text

Medicine, Hematology, Oncology +17

Biochemical, Cellular, and <i>In vivo</i> Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin

Ker Yu, Lourdes Toral‐Barza, Celine Shi et al. · Cancer Research · 2009 · 330 citations

Medicine, Oncology, Pharmacology +13

1–5 of 76